Increased prevalence of interleukin-17-producing CD4 + tumor infiltrating lymphocytes in human oral squamous cell carcinoma

Head and Neck

Volumn 33, Issue 9, 2011, Pages 1301-1308

  Lee, Jang Jaer ^a   Chang, Yen Liang ^b   Lai, Wan Ling ^c   Ko, Jenq Yuh ^c   Kuo, Mark Yen Ping ^c   Chiang, Chun Pin ^c   Azuma, Miyuki ^d   Chen, Ching Wen ^c   Chia, Jean San ^c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

IL 17; oral squamous cell carcinoma; regulatory T cells; Th17

Indexed keywords

CHEMOKINE RECEPTOR CCR6; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CANCER STAGING; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GINGIVA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE PROLIFERATION; MALE; MOUTH CARCINOMA; PREVALENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-6; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PREVALENCE; RECEPTORS, CCR6; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 80051765765     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21607     Document Type: Article

References (23)

1. Jewett A, Head C, Cacalano NA,. Emerging mechanisms of immunosuppression in oral cancers. J Dent Res 2006; 85: 1061-1073. (Pubitemid 44935523)
2. Young MRI,. Protective mechanisms of head and neck squamous cell carcinoma from immune assault. Head Neck 2006; 28: 462-470. (Pubitemid 43673082)
3. Alhamarneh O, Amarnath SMP, Stafford ND, Greenman J,. Regulatory T cells: what role do they play in antitumor immunity in patients with head and neck cancer? Head Neck 2008; 30: 251-261. (Pubitemid 351251710)
4. Yu P, Fu YX,. Tumor-infiltrating T lymphocytes:friends or foes? Lab Invest 2006; 86: 231-245.
5. Hiratsuka H, Imamura M, Ishii Y, Kohama G, Kikuchi K,. Immunohistologic detection of lymphocyte subpopulations infiltrating in human oral cancer with special reference to its clinical significance. Cancer 1984; 53: 2456-2466. (Pubitemid 14102487)
6. p3+ T cells secreting interleukin-10 and transforming growth factor-beta mediates suppression in the tumor microenvironment. Clin Cancer Res 2007; 13: 4345-4354. (Pubitemid 47219698)
7. Yamamoto T, Kimura T, Ueta E, Tatemoto Y, Osaki T,. Characteristic cytokine generation patterns in cancer cells and infiltrating lymphocytes in oral squamous cell carcinomas and the influence of chemoradiation combined with immunotherapy on these patterns. Oncology 2003; 64: 407-415. (Pubitemid 36682955)
8. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-238.
9. Volpe E, Servant N, Zollinger R, et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses. Nat Immunol 2008; 9: 650-657. (Pubitemid 351712635)
10. Manel N, Unutmaz D, Littman D,. The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nat Immunol 2008; 9: 641-649. (Pubitemid 351714729)
11. Yang L, Anderson DE, Baecher-Allan C, et al. IL-21 and TGF-beta are required for differentiation of human TH17 cells. Nature 2008; 454: 350-352.
12. Zhou L, Chong MM, Littman DR,. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009; 30: 646-655.
13. Beriou G, Costantino CM, Ashley CW, et al. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009; 113: 4240-4249.
14. Voo KS, Wang YH, Santori FR, et al. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci U S A 2009; 106: 4793-4798.
15. Kryczek I, Liu R, Wang G, et al. FOXP3 defines regulatory T cells in human tumor and autoimmune disease. Cancer Res 2009; 69: 3995-4000.
16. Kryczek I, Banerjee M, Cheng P, et al. Phenotype, distribution, generation, functional and clinical relevance of Th17 cells in the human tumor environments. Blood 2009; 114: 1141-1149.
17. Miyahara Y, Odunsi K, Chen W, Peng G, Matsuzaki J, Wang RF,. Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci U S A 2008; 105 (40): 15505-15510.
18. Moissee P,. Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum 2003; 48: 594-601.
19. Afzali B, Lombardi G, Lechler RI, Lord GM,. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007; 148: 32-46. (Pubitemid 46365005)
20. Wu S, Rhee KJ, Albesiano E, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009; 15: 1016-1022.
21. Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H,. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med 2009; 206: 1457-1464.
22. Acosta-Rodriguez EV, Rivino L, Geginat J, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007; 8: 639-646. (Pubitemid 46785128)
23. Ito T, Hanabuchi S, Wang YH, Park WR, Arima K, Bover L,. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 2008; 28: 870-880.